Category: Data Analysis

2024 Outlook: Data-Driven Transformations in the Indian Insurance Brokerage Industry

2024 Outlook: Data-Driven Transformations in the Indian Insurance Brokerage Industry

The Indian insurance brokerage ecosystem has witnessed rapid change in recent years, driven by data-driven transformations. This has revamped overall decision-making, marketing, and customer support in a major way and the trend looks set to continue in the future. Here is a closer look at how data-based transformation will ultimately impact the operations of brokerages in the Indian insurance market in 2024 and beyond.  Ways in Which Insurance Brokers Will Leverage Data Data analytics in insurance will be a major game-changer shortly for brokers. Indian insurance brokerages will ultimately turn to these models of operation.  Brokerages will also embrace technology to offer customers better services across WhatsApp, emails, SMS, or phone among other channels. They can reach out better to customers at the right time and place along with forecasting buying trends and patterns. Data analytics will help with customer behavior analysis which will unearth several invaluable insights in turn for brokers. The end goal will be to provide customised and need-based solutions across segments. Target consumers can be easily identified and segmented while products can be tailored to meet their needs. Brokerages can also leverage technology to help insurers with better underwriting, eliminating fraud enabling risk management, and maximising usage of alternate data sources. They can also use data for collaborations with other parties for specific use cases and scenarios.  These are some of how Indian insurance brokerages will gradually adopt data-driven transformations to help build competitive advantages throughout the insurance landscape.  FAQs What key data-driven transformations are anticipated for the Indian insurance brokerage industry in 2024?  The Indian insurance brokerage industry in 2024 could adopt several data-driven transformations including personalised customer products and services along with automated and faster claim settlements and processing. They can also delve into personalised pricing decisions and models to benefit their customers.  What role will emerging technologies play in shaping the data-driven landscape of Indian insurance brokerages in 2024?  Several emerging technologies like AI, automation, machine learning, and data analytics will have a vital role to play in shaping the entire data-based Indian insurance brokerage landscape in 2024. They will make it easier to build customer profiles, target and segment customers in specific categories, predict customer buying patterns based on behavioural habits and preferences, and customise products/services and pricing accordingly among many other use cases.  In what ways will data analytics impact risk management and decision-making processes for Indian insurance brokers in 2024? Data analytics will help Indian insurance brokers make better decisions and manage risks more effectively in 2024 and beyond. Analytics will help them identify potential risks at the customer’s end and also eliminate the chances of fraud. At the same time, it will help make better decisions on personalising pricing as per customer habits and lifestyle preferences. It will also help make better decisions on policy issuance depending on customer data from multiple channels. 

Read More »
How Indian BFSI Firms are Thriving through Data-Driven Strategies

How Indian BFSI Firms are Thriving through Data-Driven Strategies

BFSI firms in India are innovatively leveraging data-driven strategies to thrive and flourish in recent times. Online banking has already generated customer expectations regarding cutting-edge services irrespective of location and time. Open banking and embedded finance have also raised the bar further, enabling customers to get credits through non-bank enterprises. Open banking is also enabling third-party access through APIs to financial information. With the increase in advanced banking operations, customers are steadily expecting their institutions to anticipate their needs better.  At the same time, another indicator for BFSI firms about using data analytics in BFSI is to enable better customer experiences for future growth. A Salesforce report in 2019 covered 8,000 business customers and buyers globally and reported how 84% of customers feel that customer experiences are as crucial as the services and products offered by any financial institution. Data shared across multiple touch points and channels have thus opened up several new opportunities for BFSI players throughout the Indian finance sector to flourish amidst a competitive landscape.  How Data-Driven Strategies are Helping BFSI Firms Flourish  Data analytics in BFSI and other data-driven strategies are enabling BFSI firms in India to thrive and grow in the present scenario. Here are some pointers worth noting in this regard.  It is a fast-changing world that necessitates the usage of data-driven strategies across the board for BFSI firms. The digital banking platform segment is already expected to grow by a whopping 11.2% (CAGR or compounded annual growth rate) from 2021 to the year 2026. Bots are leveraging data to provide better customer service across touchpoints without requiring branch visits or conversations with agents. They can service customer requests easily while handling other activities seamlessly.  Conversational AI platforms are also using NLP that is integrated with IVR systems. These systems can take calls by answering repetitive questions and prevent any customer panic. Customers are assisted in swiftly resolving queries while calls that are complex are transferred to agents. Banks are offering branch-like services with data-driven strategies, building customer profiles/personas, predicting behaviour, and recommending ideal financial services and products.   Fraud detection and security models are trained on continual incoming data, helping BFSI firms know more about normalised activity levels, transaction anomalies, deviations, and more. Another method is behavior profiling which studies customer data and accounts to build profiles and understand where/what kind of transactions have taken place. Prescriptive analytics also helps leverage the data that is gathered by predictive analytics to recommend the measures to be taken once fraud is identified. These are some of the many ways in which data-driven approaches are helping BFSI players thrive in an increasingly competitive Indian finance sector. As they say worldwide, data is the new oil and it will soon be the differentiator and competitive advantage that companies in every sector will want to harness, banking and financial services included.  FAQs What key benefits do Indian BFSI firms experience through the adoption of data-driven approaches?  Data-driven approaches are helping BFSI firms in India obtain several major benefits including the ability to personalise products/services for customers, identify and eliminate fraud, predict risks and manage them accordingly, and a lot more.  In what ways are data-driven strategies enhancing decision-making within the Indian BFSI sector? Data-driven strategies are boosting overall decision-making within the Indian BFSI sector. Banks and financial institutions are leveraging data to make better decisions on granting loans or other products, offering personalised services or solutions to customers, identifying and mitigating risks, and so on. 

Read More »
Natural Language Processing (NLP) in Healthcare and Life Sciences Market 2023-2030

Natural Language Processing (NLP) in Healthcare and Life Sciences Market 2023-2030 | The Revolution of Analytics Industry

Natural language processing (NLP) is widely hailed as a future game-changer that will revolutionize various industries, including healthcare and life sciences. There are diverse NLP applications in the space which may foster an industry revolution in the future years. According to research reports, the NLP segment in the healthcare and life sciences category saw sizable revenue growth in 2022 with future forecasts of an increase by 2030. Here are some fascinating trends that industry watchers should keep an eye on.  Biggest NLP Providers in Healthcare and Life Sciences Some of the largest natural language processing (NLP) providers in this category globally include:  Key Trends in Natural Language Processing (NLP) for the Healthcare and Life Sciences Industry Here are some key facets that point towards an industry revolution driven by NLP applications in the healthcare and life sciences sectors.  Following current trends, NLP is poised to witness widespread adoption throughout the healthcare and life sciences industry. Healthy market size growth forecasts for the sector are based on extensive R&D and innovations done by leading players across major global regions. The suite of applications will only increase over the years, with better data extraction and comprehension for enhancing the overall efficiency of the healthcare and life sciences sectors.  FAQs The NLP market is poised to touch a handsome USD $ 9.54 billion by 2030, which indicates a CAGR of 19.1% from the 2022 market size of USD $ 2.35 billion.  Natural language processing (NLP) in healthcare and life sciences offers technology-driven abilities with regard to identifying contexts for the usage of words. This enables a more accurate understanding and interpretation of conversations with patients and other stakeholders while capturing vital nuances of health conditions. This helps manage treatment data and follow-ups. It also helps identify data patterns and automates various tasks in the life sciences and pharmaceuticals sector.  NLP is helpful for processing the electronic health records (EHRs) of patients with an aim to extract valuable information including medication, diagnosis, and other symptoms. This helps enhance overall patient care while ensuring personalized treatments accordingly.  4. What is the future of natural language processing?  Natural language processing (NLP) is expected to expand in the future with diverse applications and other possibilities. There will be more cutting-edge technological innovations in segments like sentiment analysis, speech recognition, Chatbots, and automated machine translation among others. 

Read More »
Latest Technologies and Future Trends by Top Key Players Forecast to 2030

Latest Technologies and Future Trends by Top Key Players Forecast to 2030

Several emerging technologies are poised to bring about a massive industry transformation as per reports. What is the forecast for future trends and the top key players till 2030? Here’s finding out.  Major Findings Here are some interesting findings related to technological advancements and technological disruptions throughout industries. It also offers insights into the future trends regarding emerging technologies.  Some Other Crucial Insights Here are a few other innovation forecast moot points for the period till 2030:  As can be seen, widespread transformation is at the core of business operations and efficiencies in the period till 2030. What the world is currently witnessing is a transitional phase with several emerging technologies being adopted by leading players in the Asia-Pacific and even worldwide. What is evident is that 2030 will push the bar well higher in terms of disruptions and eventual progress.  FAQs Some of the technologies that are already shaping the business landscape include automation and artificial intelligence, along with machine learning and IoT (Internet of Things). Other examples include data analytics and cloud computing along with blockchain technology. Organizations are steadily embracing these technologies to boost efficiency and offer more personalization to customers while also streamlining their internal operations or business processes. By 2030, the physical and digital worlds will also merge with technologies like AR, VR and 3D being used for creating digital twins in sectors like healthcare, manufacturing, real estate and more. There will also be a shift towards data native from cloud-native along with generative AI usage for closing up gaps between insights and data.  2. Who are the key players in these emerging technologies, and what are their roles in driving innovation? There are several key players for these emerging technologies from multiple standpoints. Countries like Japan, India, South Korea, and China are at the cusp of greater breakthroughs in terms of technological integration into the public and corporate spheres for greater efficiency, mitigation of risks, and many other purposes. At the same time, leading tech giants have a big role to play in terms of innovation and experimentation in order to drive future progress. The biggest players in these segments are chief technology officers or CTOs of companies. They have a vital role in terms of encouraging more innovation and building future technology blueprints for organizations.  There are a few challenges linked to the adoption of new technologies. These include legacy systems and perspectives, lack of training or skill sets, costs of new technologies and tools, and the speed of technological advancements, along with privacy concerns. The latter can be addressed through encryption measures, audits, and compliance with better regulations. Steady investments in up-skilling, training, and future-ready digital infrastructure are also the way forward with regard to tackling these challenges.  Several emerging technologies are poised to have a disruptive effect on various global sectors. Retail will witness a complete revamping of business strategies and models, becoming more personalized and data-driven with technological disruption. Industries like healthcare, manufacturing, insurance and finance should also witness major disruptions in the near future. 

Read More »
LIFE SCIENCE & PHARMA NEWS WWRAP

Life Science & Pharma News Wrap | Weekly Snippets

✅ NanoTemper Technologies launches a Biotinylated Target Labeling Kit that aims at transforming the way scientists in the pharma landscape approach challenging drug targets.https://ow.ly/Bon150P5YtC ✅ Nvidia is driving advancements for a healthier future in the pharma and healthcare landscape with Generative AI. https://ow.ly/STL850P5YtJ ✅ MeitY-nasscom CoE is all set to host an exclusive forum on the transformative power of AI in the healthcare domain.https://ow.ly/fmBH50P5YtE ✅ Scientists have developed an advanced genetic technology to combat malaria-spreading mosquitoes. This advancement brings us one step closer to eliminating malaria and saving millions of lives worldwide.https://ow.ly/GC4Y50P5YtF

Read More »
Addressing drug shortages with advanced analytics

Addressing drug shortages with advanced analytics

Drug shortages have become a part and parcel of modern healthcare systems due to several reasons. While there is a sizeable economic impact of drug shortages for manufacturers and pharmacies alike, there are widespread community and social disadvantages as well. Pharmacies or clinics running out of medicine stocks are representatives of a scenario that is often witnessed worldwide and with frightening consequences.  For example, Europe is already seeing shortages of commonly-used medicines. A survey by the Pharmaceutical Group of the European Union (EU) had 100% of 29 member nations reporting shortages of medicines amongst community pharmacists. 76% also stated how shortages had worsened than the earlier year (the survey was implemented between 14th November and 31st December 2022). The UK is also witnessing HRT shortages according to reports, while hospitals in the U.S. are also reporting issues with procurement for liquid ibuprofen, while ADHD diagnoses have gone up in the U.S. as well, leading to shortages of vital drugs for the same. Mexico is witnessing chronic shortages and unfulfilled prescriptions and supply fluctuations and disruptions have been seen widely throughout Asia too.  What are the reasons for medicine shortages?  Wondering about the reason for drug shortages? There are quite a few that can be noted in this context:  Higher seasonal illness outbreaks in the aftermath of COVID-19, leading to skyrocketing average annual demand for medicines that is higher than normal in several categories.  The inability of pharmaceutical companies to meet such unprecedented demand, with excess capacity restricted for cost control.  Global supply chain impact along with higher energy costs and inflation have impacted global drug manufacturers who have to contend with pricing measures.  Stockpiling by customers due to sudden drug shortages.  Over-prescribing by the system.  Reports estimate that the National Health Service in the UK loses a whopping 300 million pounds annually owing to partially-used or unused medication which cannot be reused or recycled.  Lack of systems for forecasting and identifying supply shortages, while ensuring proper inventory management.  Drug Shortage Solutions That May Work  There are a few drug shortage solutions that may be effective for combating and reducing shortages.  Data and analytics are enabling better access towards medicines worldwide while enabling superior supply and demand management for individual patients and pharmacies alike.  Real-time pharmacy, hospital, and clinical data will enable a proper understanding of the demand for specific drugs/medical products.  Leveraging electronic and public health records for enabling healthcare stakeholders to report demand figures for drugs, without revealing confidential patient data.  Opportunities for better inventory and supply chain management with AI (artificial intelligence) and machine learning (ML).  Generic entities may leverage smarter technologies for lowering manufacturing costs by up to 20% while enhancing production. Smarter and connected factories with proper insights and data analysis can enable higher savings and reliable deliveries.  Companies may look at higher procurement of local active ingredients while depending on go-to nations for the same. Boosting supply and production levels, along with harnessing real-time data analytics will enable tackling this scenario.  Supervised machine learning and analytics models can help in forecasting/predicting shortages for most drugs used throughout various categories, price points, and age groups.  Modelling can enable healthcare stakeholders to understand more about the issues behind drug shortages while analytics can also help predict demand for specific drugs based on historical data and current trends.  Pharmacies and other players may not have access to data on the supply side, although they have demand-side information. They will be able to gain more visibility into the supply chains of manufacturers with an integrated information-sharing system.  Data analytics-driven insights for optimizing orders and eventually lowering the effect of drug shortages on pharmaceutical and healthcare operations.  Systems for tracking and reporting drug shortages, including aspects like the frequency, drugs involved, period, causes, duration, managing strategies, impacts, and future shortages too.  Real-time identification and tracking of patients receiving shorter supplies of drugs by hospitals, clinics, and pharmacies. Immediate patient identification regulations for capturing present drug utilization across multiple categories.  Real-time identification and addressing situations along with finding out drugs in shorter supply. Predictive abilities enable higher time for researching material for alternative agents or making suitable arrangements for drug acquisition from other sites or facilities.  Once supply levels normalize for a drug, pharmacists and healthcare stakeholders may discontinue their surveillance regulations without waiting for technical assistance. Real-time data-filtering and reporting abilities are leveraged for viewing drug usage trends and prescription patterns throughout healthcare systems. These insights may enable higher standardization of drug management across institutions, while also facilitating better training of clinicians for lowering care variations.  Advanced data analytics will help address drug shortages and enable better inventory management simultaneously. However, suitable implementation, technological integration, and awareness are necessary for the same.  FAQs How can advanced analytics be used to address drug shortages? Advanced analytics can be deployed for tackling drug shortages through real-time tracking and surveillance of prescription trends and drug demand, forecasting shortages, and enabling better drug supply management.  What are the benefits of using advanced analytics to address drug shortages? Advanced analytics goes a long way towards helping tackle drug shortages, enabling forecasting future demand and shortages, identifying patterns for better management, and also enabling better global medicine access.  What are the challenges of using advanced analytics to address drug shortages? Challenges include technological integration, legacy systems integration, awareness regarding best practices, quality data generation, and more.  What are the best practices for implementing advanced analytics for drug shortage management? Best practices include unified and integrated public databases, suitable data modelling systems, suitable protocols for data security and privacy, and swift reporting mechanisms for demand and shortages.

Read More »
Data analytics plays a crucial role in clinical trial design and analysis by providing valuable insights into the effectiveness of new treatments and therapies.

The role of data analytics in clinical trial design and analysis

What is the role of data analysis in clinical trials? Can there be better clinical trial data analysis using R and other technologies? Is there a case for using big data analysis in clinical trials? Experts would certainly say Yes to all these questions. Clinical trials themselves have gone through sweeping changes over the last decade, with several new developments in immunotherapy, stem cell research, genomics, and cancer therapy among numerous segments. At the same time, there has been a transformation in the implementation of clinical trials and the process of identifying and developing necessary drugs.  To cite a few examples of the growing need for clinical trial data analysis, researchers gain quicker insights through the evaluation of databases of real-world patient information and the generation of synthetic control arms, while identifying drug targets alongside. They can also evaluate drug performance post-regulatory approvals in this case. This has lowered the cost and time linked to trials while lowering the overall burden on patients and enabling faster go-to-market timelines for drugs too.  What is driving data analysis in clinical trials?  Clinical trial data analysis is being majorly driven by AI (artificial intelligence) along with ML (machine learning), enabling the capabilities of collection, analysis, and production of insights from massive amounts of real-time data at scale, which is way faster than manual methods. The analysis and processing of medical imaging data for clinical trials, along with tapping data from other sources is enabling innovation of the entire process while being suitable for supporting the discovery procedure in terms of quickening the trials, go-to-market approaches, and launches.  The data volumes have greatly increased over the last few years, with more wearable usage, genomic and genetic understanding of individuals, proteomic and metabolomic profiles, and detailed clinical histories of patients derived from electronic health records. Reports indicate 30% of the data volumes of the world are generated by the global healthcare industry. The CAGR (compound annual growth rate) for healthcare data will touch 36% by the year 2025 as well. The volume of patient data in clinical systems has already grown by a whopping 500% to 2020 from 2016.  Data analysis in clinical trials- What else should you note?  Here are a few factors that are worth noting:  Synthetic control arm development  The role of data analysis in clinical trials is even more evident when one considers the development of synthetic control arms. Clinical drug discovery and trials may be fast-tracked while enhancing success rates and designs of clinical trials. Synthetic control arms may help in overcoming challenges linked to patient stratification and also lower the time required for medical treatment development. It may also enable better recruitment of patients through resolving concerns about getting placebos and enabling better management of diverse and large-sized trials.  Synthetic control arms tap into both historical clinical trials and real-world data for modelling patient control groups and doing away with the requirement for the administration of placebo treatments for patients which may hinder their health. It may negatively impact patient outcomes and enrolment in trials. The approach may work better for rare ailments where populations of patients are tinier and the lifespan is also shorter owing to the disease’s virulent nature. Using such technologies for clinical trials and bringing them closer to end-patients may significantly lower the overall inconveniences of travelling to research spots/sites and also the issue related to consistent tests.  ML and AI for better discovery of drugs ML and AI may enable a quicker analysis of data sets gathered earlier and at a swifter rate for clinicians, ensuring higher reliability and efficiency in turn. The integration of synthetic control arms in mainstream research will offer new possibilities in terms of transforming the development of drugs.  With an increase in the count of data sources including health apps, personal wearables and other devices, electronic medical records, and other patient data, these may well become the safest and quickest mechanisms for tapping real-world data for better research into ailments with sizeable patient populations. Researchers may achieve greater patient populations which are homogenous and get vital insights alongside. Here are some other points worth noting:  The outcomes of clinical trials are major metrics with regard to performance, at least as far as companies and investors are concerned. They are also the beginning of collaborations between patients, groups, and the healthcare sector at large. Hence, there is a clearly defined need for big data analysis in clinical trials as evident through the above-mentioned aspects.  FAQs How can data analytics be used in clinical trial design and analysis? Data analytics can be readily used for clinical trial design and analysis, expanding patient selection criteria, swiftly sifting through various parameters and helping researchers better target matching patients who match the criteria for exclusion and inclusion. Data analysis methods also enable better conclusions from data while also improving clinical trial design due to better visibility of the possible/predicted risk-reward outcomes.  What are the benefits of using data analytics in clinical trial design and analysis? The advantages of using data analytics in clinical trial design and analysis include the integration of data across diverse sources, inclusive of third parties. Researchers get more flexibility in terms of research, finding it easier to analyze clinical information. Predictive analytics and other tools are enabling swifter disease detection and superior monitoring.  What are the challenges of using data analytics in clinical trial design and analysis? There are several challenges in using data analytics for the analysis and design of clinical trials. These include the unavailability of skilled and experienced resources to implement big data analytics technologies, data integration issues, the uncertainty of the management process, storage and quick retrieval aspects, confidentiality and privacy aspects and the absence of suitable data governance processes.  What are the best practices for implementing data analytics in clinical trial design and analysis? There are numerous best practices for the implementation of data analytics for the analysis and design of clinical trials. These include good clinical data management practices, clinical practices, data governance

Read More »
Sentiment Analysis

How Sentiment Analysis Can Drive Insurance Industry

Sentiment analysis in insurance is emerging as a potent tool for companies in multifarious ways. Insurance companies have tons of unstructured information that they have at hand.  Following a suitable sentiment analytics process may help insurers enhance retention of policyholders and also in the identification of opportunities pertaining to up-selling and cross-selling. Sentiment analytics have already turned into a vital aspect of strategies pertaining to customer feedback for companies of diverse sizes. Sentiment analytics in insurance fuse Machine Learning (ML) and Natural Language Processing (NLP) along with deep-text analytics for illuminating intrinsic nuances of texts.  Sentiments can be translated more easily and analyzed seamlessly than expressions. The sentiment analytics process is also known as opinion mining.  Customer data is unstructured and comes in several forms including claim data, voice messages, surveys, emails, social media posts. The entire system is tailored not only to analyze feedback and its nature, but also to put it against the right context. Benefits of Sentiment Analytics Insurers can reap multiple benefits from suitable sentiment analysis procedures. Here’s looking at some of them: 1. Detecting Fraud Reports indicate how insurers lose millions annually on account of fraud. These are estimated at anywhere around 5-10% of total compensation payouts by insurers in a year at least.  These are claims that flew under the radar. However, predictive analytics and other tools can help detect the same. A sentimental analysis dataset will help insurance companies track and assess insurance settlement and claim patterns.  It will help in quicker decision-making on the basis of crucial parameters or key performance indicators. This will help in arresting fraudulent claims and enhance the insurer’s earnings.  Text analytics also enables better decision-making through dashboards and access to other necessary data. 2. Customer Understanding  Social media sentiment analysis will help in the classification and identification of customer interactions on the basis of parameters like the services/products being provided, the marketing platforms or channels that are used, the operations in place and so on.  What sentiment analysis does is help insurers understand the voices of their customers.  It fosters superior customer understanding above everything else. Social media datasets will help in the identification of specific aspects concerning any product, process, or service.  Whenever this analysis is implemented for social media comments, it helps in clearly delineating trends in the industry and perceptions of companies along with enabling timely alerts on any reputation related issues as well. 3. Managing Claims The analysis of complaints and claims is another natural segment for using such datasets. Complaints may be automatically identified and classified on the basis of the service, product and other parameters.  This enables passing them onto suitable agents/departments in order to ensure swift action on the same. Relating those to real world Sentiment analysis in insurance reduces costs, combats fraudulent claims, helps insurance companies understand patterns, trends and customer preferences, and also lowers overall workload and the time taken to respond to customer issues.  Simultaneously, social media sentiment analysis helps in enhancing satisfaction levels of both employees and clients, while enhancing client retention, brand-building, recommendations.  It also goes a long way towards lowering indirect expenditure. Sentiment analytics can help insurance companies keep leveraging unstructured information for identification of revenue-enhancing opportunities and industry/customer trends.  Although analytics is not perfect as of yet, it is continually evolving towards the same. In this case, the sustained focus on a specific domain (insurance) can help in enhancing the overall accuracy levels as well. Indus Net Technologies offers an array of solutions tailored towards the needs of insurance companies and the industry at large, right from cutting-edge analytics and other technological tools to back-end automation, risk profiling, customizable analytics, and modernization of legacy applications.  Having worked on diverse task requirements for insurers over the years, INT has the ability to tailor industry and company-specific solutions that harness the power of data, free up company resources, and ultimately boost company revenues and growth alike. About the author: Dipak Singh is a thought leader and data cruncher, currently, he heads the Analytics Wings at INT. To know more do check out his LinkedIn profile here.

Read More »
MENU
CONTACT US

Let’s connect!

    Privacy Policy.

    Almost there!

    Download the report

      Privacy Policy.